The Beauty Health surged 13.95% intraday, driven by its Q3 earnings report showing $70.7 million in revenue (exceeding the $68.6 million analyst estimate) and an upwardly revised FY2025 sales guidance to $293–$300 million (above the $293.8 million market forecast). The growth in consumables—single-use tools and serums—boosted adjusted gross margin to 68%, offsetting declining equipment sales and contributing to profitability improvements.
Comments
No comments yet